OTLKW

Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022

Delisted

OTLKW was delisted on the 16th of February, 2022.

4 hedge funds and large institutions have $61K invested in Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022 in 2021 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
1
Closed
Calls
$171K
Puts
Net Calls
+$171K
Net Calls Change
-$101K

Top Buyers

No buyers this quarter
Name Holding Trade Value Shares
Change
Shares
Change %
CAM
1
Cormorant Asset Management
Massachusetts
$32K
SFM
2
Sphera Funds Management
Israel
$15K
PC
3
PointState Capital
New York
$10K
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$4K -$6.24K -48,061 -61%